Impact of an Antibiotic (Rifaximin) on Liver Scarring in HIV-Infected Patients With Liver Disease
Clinical trial NCT01654939 · WITHDRAWN
Trial details
- NCT number
- NCT01654939
- Sponsor
- Douglas T. Dieterich
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2014-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.